Philip A. van Damme
Fondateur chez Stichting Sanammad
Postes actifs de Philip A. van Damme
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Stichting Sanammad | Directeur/Membre du Conseil | 01/01/2009 | - |
| Fondateur | 01/01/2009 | - | |
| President | 01/01/2009 | - | |
| Sanammad Pharmaceuticals BV | Directeur/Membre du Conseil | 01/01/2014 | - |
| Fondateur | 01/01/2014 | - | |
| President | 01/01/2014 | - |
Historique de carrière de Philip A. van Damme
Anciens postes connus de Philip A. van Damme
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Directeur/Membre du Conseil | 01/05/2014 | 06/05/2020 |
| Directeur Technique/Scientifique/R&D | 01/05/2014 | 06/05/2020 | |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Directeur/Membre du Conseil | 01/01/2012 | - |
| Directeur Technique/Scientifique/R&D | 30/07/2013 | - |
Formation de Philip A. van Damme
| University of Utrecht | Doctorate Degree |
Statistiques
Internationale
| Pays-Bas | 5 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV |
- Bourse
- Insiders
- Philip A. van Damme
- Expérience
